Edition:
United Kingdom

Chembio Diagnostics Inc (CEMI.OQ)

CEMI.OQ on NASDAQ Stock Exchange Capital Market

7.30USD
15 Dec 2017
Change (% chg)

$0.25 (+3.55%)
Prev Close
$7.05
Open
$7.10
Day's High
$7.30
Day's Low
$7.10
Volume
3,636
Avg. Vol
4,002
52-wk High
$7.50
52-wk Low
$5.05

Latest Key Developments (Source: Significant Developments)

Chembio Diagnostics Awarded UNICEF Contract
Tuesday, 28 Nov 2017 

Nov 28 (Reuters) - Chembio Diagnostics Inc ::CHEMBIO DIAGNOSTICS AWARDED UNICEF CONTRACT TO SUPPLY POINT-OF-CARE DPP® ZIKA ASSAYS AND DPP® MICRO READERS.CHEMBIO DIAGNOSTICS INC - ‍CO HAS BEEN AWARDED A CONDITIONAL LONG TERM ARRANGEMENT FROM UNICEF FOR PURCHASES OF COMPANY'S DPP ZIKA SYSTEM​.CHEMBIO DIAGNOSTICS - ‍UNICEF LTA, WHICH IS VALID THROUGH DEC 31, 2019, INCLUDES PURCHASE COMMITMENT OF $1.5 MILLION, POSSIBLE PURCHASES UP TO $3.4 MILLION.  Full Article

Chembio Diagnostics posts Q3 loss of $0.05 per share
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Chembio Diagnostics Inc :Chembio diagnostics reports third quarter 2017 financial results.Q3 loss per share $0.05.Q3 revenue rose 102 percent to $7.6 million.  Full Article

Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands
Friday, 23 Sep 2016 

Chembio Diagnostics Inc : Chembio expands exclusive distribution agreements with Isla Lab to include Puerto Rico and U.S. Virgin Islands . Isla Lab becomes Chembio's exclusive distribution partner throughout Caribbean region, including Puerto Rico and U.S. Virgin Islands .Entered into an exclusive distribution agreement with Isla Lab LLC that includes both Puerto Rico and U.S. Virgin Islands.  Full Article

Chembio enters into exclusive agreement with Isla Lab
Thursday, 18 Aug 2016 

Chembio Diagnostics : Chembio expands product distribution through exclusive agreement with Isla Lab in the Caribbean . Entered into agreement with Isla Lab Caribbean, which covers twenty-five nations in Caribbean, excluding Puerto Rico, U.S. Virgin Islands .Agreement with Isla Lab Caribbean initially includes co's products, which have met regulatory requirements to be sold in Caribbean region.  Full Article

Chembio Diagnostics Q2 loss per share $0.86
Thursday, 11 Aug 2016 

Chembio Diagnostics Inc : Q2 loss per share $0.86 .Q2 revenue fell 51.4 percent to $3.27 million.  Full Article

Chembio's Zika test cleared for sale in Europe and Caribbean
Wednesday, 27 Jul 2016 

Chembio Diagnostics Inc :Chembio's DPP Zika IgM/IgG assay obtains CE mark for rapid point-of-care detection of Zika virus.  Full Article

Chembio Diagnostics says proposed public offering of shares
Monday, 25 Jul 2016 

Chembio Diagnostics Inc : Chembio Diagnostics announces proposed public offering of common shares .Has commenced an underwritten public offering of $10.0 million of common shares.  Full Article

Chembio Diagnostics posts Q1 loss per share of $0.03
Thursday, 12 May 2016 

Chembio Diagnostics Inc : Chembio Diagnostics reports first quarter 2016 financial results . Q1 loss per share $0.03 .Q1 revenue rose 5.9 percent to $6.6 million.  Full Article

Chembio Diagnostics, Inc to collaborate with Bio-Manguinhos/to develop Zika Diagnostic Tests
Monday, 7 Mar 2016 

Chembio Diagnostics, Inc:To collaborate with bio-manguinhos/fiocruz to develop point-of-care zika diagnostic tests for Brazil.Says plans to collaborate with bio-manguinhos/fiocruz for the development of poc zika diagnostic tests for Brazil.Says Chembio will add zika to the poc dpp fever panel assay that is currently under development.  Full Article

Chembio Diagnostics receives award for development of point-of-care diagnostic tests
Friday, 19 Feb 2016 

Chembio Diagnostics Inc:Awarded grant from paul g. allen family foundation to develop point-of-care diagnostic tests for zika virus and related febrile illnesses.  Full Article

BRIEF-Chembio receives $8.5 mln commitment from Bio-Manguinhos to purchase components for production of dpp Assays in Brazil during 2018

* CHEMBIO RECEIVES $8.5 MILLION COMMITMENT FROM BIO-MANGUINHOS TO PURCHASE COMPONENTS FOR PRODUCTION OF DPP® ASSAYS IN BRAZIL DURING 2018